FDA Says Data Manipulated for Novartis Gene Therapy Drug – The Wall Street Journal

Business News

FDA Says Data Manipulated for Novartis Gene Therapy Drug  The Wall Street Journal

The Food and Drug Administration said “data manipulation” took place during the clinical trial of Zolgensma, the world’s most expensive drug, but officials said …

View full coverage on Google News
Source: Business News